UK Consumers have gradually shifted towards rechargeable products

Apr.22.2025
UK Consumers have gradually shifted towards rechargeable products
Disposable e-cigarette usage in the UK is declining as consumers shift towards refillable products, particularly among 16-24 year-olds.

Key Points:

Usage of disposable e-cigarettes is declining: a study has found that in the UK, the ban on disposable e-cigarettes has not yet come into effect, and consumers have gradually shifted towards rechargeable products, resulting in a significant decrease in usage, particularly among the 16-24 age group.

Overall usage rates tend to stabilize: Data from 2022 to 2024 shows that the e-cigarette usage rate in the UK has increased before stabilizing, with restrictions having limited impact on the overall trend.

Policy recommendations lean towards caution: researchers warn that further restrictions may hinder smokers' paths to quitting, and suggest focusing on limitations on marketing displays and advertising.

The government and industry have reached a consensus on the need to protect young people and support adult smoking cessation goals. The government encourages evaluating next steps after the implementation of existing policies.


According to a report by The Independent on April 16, a recent study funded by Cancer Research UK showed that the upcoming disposable e-cigarette ban in the UK may have limited impact on the number of e-cigarette users. The study indicated that since the announcement of the ban, people have been increasingly turning to refillable e-cigarette devices.

 

A study based on data from the Smoking Toolkit Study analyzed a total of 88,611 adults in the UK, Wales, and Scotland from January 2022 to January 2024. The data showed that the e-cigarette usage rate among individuals aged 16 and above increased from 8.9% to 13.5%; with the proportion of disposable e-cigarette users decreasing from 43.6% to 29.4%. Researchers pointed out that the decrease was particularly pronounced among the 16 to 24 age group.

 

Scholars at University College London (UCL) have pointed out that the rapid growth of e-cigarette use in the UK in recent years has now plateaued. They have warned that proposed "more strict policies" could hinder smokers from using e-cigarettes to quit smoking. Previously, the UK government announced a ban on disposable e-cigarettes starting on June 1, 2025.

 

The Tobacco and E-cigarette Act currently under review in Parliament also includes provisions that could restrict the packaging, marketing, and flavors of e-cigarettes.

 

Dr. Sarah Jackson from the UCL Institute of Epidemiology and Health Care, who participated in the study, stated that

 

Research results indicate that the ban on disposable e-cigarettes implemented in June may have limited impact on the overall e-cigarette usage rates, as users have already been shifting towards other types. While actions still need to be taken to reduce high usage rates, decision-makers may find that stricter policy options currently under consideration should be avoided, as the situation has stabilized.

 

Other researchers suggest that "the recent e-cigarette use rate in the UK has stabilized." Analysis found that from January 2022 to January 2024, the e-cigarette use rate among adults increased from 8.9% to 13.5%, while the proportion among young adults increased from 17% to 26.5%.

 

Scholars say that...

 

After the announcement of the new policy measures in January 2024, there was a noticeable change in the trend of e-cigarette usage. Among adults and young adults, the usage rates no longer increased, but rather remained relatively stable.

 

Professor Jamie Brown, from the London School of Hygiene and Tropical Medicine, believes that...

 

While it is understandable that policymakers want to reduce the use of e-cigarettes among children and non-smokers, smoking remains a top public health priority.

 

He suggested prioritizing policies that create less disruption in the path to quitting smoking, such as restricting marketing, packaging, and product displays, combined with public education and support measures like the "quit smoking by substituting" program.

 

Caroline Cerny, Vice Chair of the public health charity Action on Smoking and Health (ASH), believes that research showing government policies are impacting industry and consumer behavior is a positive sign. She emphasizes the need to support adult smokers in their efforts to quit while also protecting youth.

 

Gillian Golden, Chief Executive of the Independent British Vape Trade Association (IBVTA), welcomed the gradual abandonment of disposable products by consumers before the ban, and called on regulatory agencies to carefully assess the effects before implementing new regulations. She added that in the UK, e-cigarette sales are already prohibited to those under 18, and nearly 3 million people have successfully quit smoking through e-cigarettes, with nearly 6 million smokers still able to benefit from safer alternatives.

 

A spokesperson for the British government stated that the research provides positive evidence that the growth in teenage e-cigarette use is stabilizing. The government continues to promote the health advice that e-cigarettes should be used as a smoking cessation tool for adult smokers, and not for children or non-smokers.

 

The upcoming Tobacco and E-cigarette Act will grant the government the power to regulate the packaging, flavors, and marketing of e-cigarettes, with the goal of creating a smoke-free generation.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
At InterTabac 2026 in Dortmund, PMI is presenting multiple brands and products along “The PMI Boulevard,” including IQOS, ZYN, VEEV and Marlboro. On-site images captured by 2Firsts show dedicated spaces including the IQOS Boutique, ZYN Café, PMI Gallery and Marlboro Office
Market
Sep.16 by 2Firsts Perspectives
Juul Displays FDA-Authorized JUUL2, Highlights Age Verification at NACS Show 2026
Juul Displays FDA-Authorized JUUL2, Highlights Age Verification at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Juul Labs displayed its JUUL2 e-cigarette system alongside existing products, age-verification messaging and mobile coupons, 2Firsts observed. The JUUL2 device and Virginia Tobacco and Polar Menthol pods received FDA marketing authorization in August 2026. Booth materials highlighted longer battery life, greater e-liquid capacity and connected-device features. A TruAge sign and a mobile coupon presentation also featured at the booth, with weekly offers available to age-verified adult nicotine consumers at participating retailers.
EXPO
Oct.09
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
A study by CDC Foundation researchers found no sustained decline in e-cigarette sales across Alabama, Oklahoma and Louisiana, the first three U.S. states to implement e-cigarette directory laws. Louisiana initially saw a significant sales decline, followed by a rebound and a persistent reduction in product availability. Sales also shifted from nontobacco-flavored disposables toward prefilled cartridges, with Vuse Alto driving much of the increase in menthol cartridges. By April 2025, unlisted products still accounted for more than half of e-cigarette nicotine sales in all three states.
Sep.18
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
New York City Opens Lottery for 55 Vape Retail License Slots Across 23 Community Districts, Including 28 in Brooklyn
New York City Opens Lottery for 55 Vape Retail License Slots Across 23 Community Districts, Including 28 in Brooklyn
New York City's Department of Consumer and Worker Protection (DCWP) opened applications on November 2, 2026, for a lottery covering tobacco and electronic cigarette retail dealer licenses, with a deadline of 5 p.m. New York local time on November 30. According to the city's October 1 notice, 55 electronic cigarette retail license slots are available across 23 community districts, including 28 in Brooklyn, alongside 322 tobacco retail license slots across 41 districts. Businesses must enter the lottery and, if invited, complete licensing requirements within 65 days. New York City continues to restrict e-cigarette retail sales to tobacco-flavored or unflavored products, while city retail licenses do not replace FDA product marketing authorization.
Market
Nov.04
Iowa Sets November 16 Vape Directory Launch: Unlisted Products Face Sales Ban, Manufacturers $1,000 Daily Fines per Product
Iowa Sets November 16 Vape Directory Launch: Unlisted Products Face Sales Ban, Manufacturers $1,000 Daily Fines per Product
Iowa plans to publish its first vapor products directory on November 16, 2026, after which products not listed will be prohibited from sale or offer for sale in the state. The Department of Revenue expects to begin penalty enforcement on December 17, following an initial 21-business-day period focused on compliance education. Under House File 2677, retailers, distributors and wholesalers selling unlisted products face civil penalties of $300 per product per day, while manufacturers face $1,000 per product per day. Eligibility extends to FDA-authorized products and certain products meeting historical marketing and pending PMTA requirements. The directory program resumed after a federal appeals court vacated a preliminary injunction in July 2026.
Regulations
Nov.05